Multiple studies have identified LKB1 as a tumor suppressor gene and shown that it inhibits important metabolic pathways in cancer cells by activating AMPK (Hawley et al., 2016; Blackmore et al., 2017). This evidence concerns the gene STK11 and neoplasm.